Effect of Group Preoperative Pelvic Floor Training for HoLEP
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jan 31, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether group pelvic floor training before surgery can help prevent urinary incontinence in men who are undergoing a specific type of prostate surgery called Holmium laser enucleation of the prostate (HoLEP). Urinary incontinence is when someone has trouble controlling their urine, which can be a concern after this kind of surgery. The researchers hope that by participating in this training, patients may have better outcomes and reduce the risk of incontinence after their procedure.
To be eligible for this trial, participants must be male, aged between 50 and 90, and diagnosed with benign prostatic hyperplasia (BPH), which is an enlargement of the prostate. They should be able to understand the study and give their consent to participate. However, individuals who have severe urinary incontinence due to past neurological issues, or who cannot follow the training protocol, will not be included. If you join the study, you can expect to participate in group training sessions focused on strengthening pelvic floor muscles, along with regular follow-ups to track your progress and any changes in symptoms. This research could lead to better ways to manage urinary incontinence for future patients undergoing HoLEP surgery.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Consecutive patients with a diagnosis of BPH with a plan to undergo HoLEP.
- • Between the age of 50-90.
- • Ability to understand and provide informed consent.
- Exclusion Criteria:
- • Patients whom inability to carry out PFT protocol.
- • Patients unwilling or unable to complete follow up care.
- • Severe urinary incontinence due to a history of neurological diseases such as a cerebrovascular accident or spinal cord injuries.
- • Patients whom inability to read and understand the English language.
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Thomas Chi, M.D.
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials